| Product Code: ETC10772976 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Togo continued to receive significant import shipments of peripheral T-cell lymphoma treatments, with key exporting countries including France, India, China, USA, and Denmark. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market for these imports. Despite a negative compound annual growth rate (CAGR) of -2.47% from 2020 to 2024, the growth rate in 2024 saw a steeper decline of -8.58%. This data suggests a challenging market environment for peripheral T-cell lymphoma treatments in Togo, urging stakeholders to monitor and adapt to changing dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Peripheral T Cell Lymphoma Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, 2021 & 2031F |
3.3 Togo Peripheral T Cell Lymphoma Market - Industry Life Cycle |
3.4 Togo Peripheral T Cell Lymphoma Market - Porter's Five Forces |
3.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume Share, By Treatment Method, 2021 & 2031F |
3.7 Togo Peripheral T Cell Lymphoma Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
3.8 Togo Peripheral T Cell Lymphoma Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Togo Peripheral T Cell Lymphoma Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Togo Peripheral T Cell Lymphoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Togo Peripheral T Cell Lymphoma Market Trends |
6 Togo Peripheral T Cell Lymphoma Market, By Types |
6.1 Togo Peripheral T Cell Lymphoma Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Cancer Type, 2021 - 2031F |
6.1.3 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Angioimmunoblastic T-Cell Lymphoma, 2021 - 2031F |
6.1.4 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Anaplastic Large Cell Lymphoma, 2021 - 2031F |
6.1.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Enteropathy-Associated T-Cell Lymphoma, 2021 - 2031F |
6.1.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Peripheral T-Cell Lymphoma NOS, 2021 - 2031F |
6.1.7 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Cutaneous T-Cell Lymphoma, 2021 - 2031F |
6.2 Togo Peripheral T Cell Lymphoma Market, By Treatment Method |
6.2.1 Overview and Analysis |
6.2.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.4 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Bone Marrow Transplant, 2021 - 2031F |
6.2.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Stem Cell Transplant, 2021 - 2031F |
6.2.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Togo Peripheral T Cell Lymphoma Market, By Patient Demographics |
6.3.1 Overview and Analysis |
6.3.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.3 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.3.4 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By High-Risk Patients, 2021 - 2031F |
6.3.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By General Population, 2021 - 2031F |
6.4 Togo Peripheral T Cell Lymphoma Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.4.4 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Academic Centers, 2021 - 2031F |
6.4.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.5 Togo Peripheral T Cell Lymphoma Market, By Drug Type |
6.5.1 Overview and Analysis |
6.5.2 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.5.3 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.5.4 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.5.5 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Cytotoxic Drugs, 2021 - 2031F |
6.5.6 Togo Peripheral T Cell Lymphoma Market Revenues & Volume, By Biologic Agents, 2021 - 2031F |
7 Togo Peripheral T Cell Lymphoma Market Import-Export Trade Statistics |
7.1 Togo Peripheral T Cell Lymphoma Market Export to Major Countries |
7.2 Togo Peripheral T Cell Lymphoma Market Imports from Major Countries |
8 Togo Peripheral T Cell Lymphoma Market Key Performance Indicators |
9 Togo Peripheral T Cell Lymphoma Market - Opportunity Assessment |
9.1 Togo Peripheral T Cell Lymphoma Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Togo Peripheral T Cell Lymphoma Market Opportunity Assessment, By Treatment Method, 2021 & 2031F |
9.3 Togo Peripheral T Cell Lymphoma Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
9.4 Togo Peripheral T Cell Lymphoma Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Togo Peripheral T Cell Lymphoma Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Togo Peripheral T Cell Lymphoma Market - Competitive Landscape |
10.1 Togo Peripheral T Cell Lymphoma Market Revenue Share, By Companies, 2024 |
10.2 Togo Peripheral T Cell Lymphoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here